Course curriculum

  • 1

    General Information

    • Learning Objectives

    • Course Overview
  • 2

    SESSION 1: Acute HF: Introduction and immediate management of acute HF

    • Anatomy of the aortic valve and implications for TAVI | Y. Ho

    • How imaging can guide decision making | V. Delgado

    • The Heart Team: selecting patients, current indications | B. Prendergast

    • Assessing risk before TAVI | S. Toggweiler

    • Low-flow low-gradient aortic stenosis – TAVI or AVR? | V. Delgado

    • Anatomy and imaging of the mitral valve | V. Delgado

    • Debate: Should all patients with functional MR receive TMVR? | Nickenig/Iung

    • List of Publications - Session 1
  • 3

    Session 2: Live MitraClip & Imaging Valve Disease & MR & Double Valve Disease

    • LIVE CASE: MitraClip Intervention from Bonn| G. Nickenig

    • Role of CT in selection and follow up of TAVI patients| S. Mirsadraee

    • Ultrasound guided valvular intervention | M. Zuber

    • Management of tricuspid regurgitation| A. Duncan

    • Double Valve Disease| R. Smith

    • List of Publications - Session 2
  • 4

    Session 3: Right Heart Failure & Cardio-Oncology

    • Imaging of the right heart| R. Senior

    • Causes of right heart failure| S. Rosenkranz

    • Modern management of pulmonary hypertension| L. Howard

    • Cancer and heart failure| S. Rosen

    • Cardiotoxic drugs and heart failure| T. Suter

    • Follow-up of cardio-oncology patients| T. Lopez Fernandez

    • List of Publications - Session 3
  • 5

    Session 4: Cardiogenic Shock

    • The spectrum of cardiogenic shock – infarction and/or HF| T. F. Lüscher

    • Managing cardiogenic shock – an update| H. Thiele

    • ECMO: indications and outcomes| S. Davies

    • Current management of cardiogenic shock – case examples| V. Panoulas

    • List of Publications - Session 4
  • 6

    Session 5: Percutaneous MCS & Revascularization in Ischemic Cardiomyopathy

    • Live in-a-box: Using Impella| J. Hill

    • Setting up an ECMO programme| S. Davies

    • Percutaneous LV support | P. Hunziker

    • Impella - Cases| J. Hill

    • Diagnosing ischemia and risk assessment| R. Büchel

    • Anatomical coronary complexity and procedural risk assessment| A. Baumbach

    • PCI vs. CABG vs. medical therapy and outcomes in ischemic CM | M. Petrie

    • List of Publications - Session 5
  • 7

    Session 6: Regenerative Medicine & Myocarditis & Takotsubo & Build a HF clinic

    • Genetic and epigenetic modifications | F. Paneni

    • Pluripotent stem cells for the heart | S. Harding

    • Myocarditis: causes, clinical presentation and management| S. Prasad

    • Takotsubo syndrome | J. Templin-Ghadri

    • How to build up a HF Clinic – the Swiss experience| R. Hullin

    • The role of nurses in the HF clinic | T. Jaarsma

    • The future of cardiology | T.F. Lüscher

    • List of Publications - Session 6
Please note that accreditation and certification for Module 5 - 1st Edition is possible until 30.04.2023